T ۱۳۹۶-۶-۷ ۱۹:۳۹:۲۵ +۰۰:۰۰

Project Description

T ProLymphocytic Leukemia panel at diagnosis ( 16-18 CD markers)
T(1:13) or PAX7-FKHR for Rhabdomyo sarcoma
t(1;13) PAX7/FOXO1A (FKHR) for Alveolar Rhabdomyosarcoma
t(1;13) PAX7/FOXO1A (FKHR) for Alveolar Rhabdomyosarcoma RT- PCR
 t(1;14) SIL-TAL or del(1)SIL-TAL1 for T-ALL
t(1;19)TCF3-PBX1 or E2A-PBX1 /t(1;19)
t(11;14) IgH/CCND1 for Mantle cell Lymphoma
t(11;14) IgH/CCND1 or Cyclin D1/BCL1 /t(11;14) for Mantle cell lymphoma
t(11;14)(q13;q32) IGH/CCND1 for Mantle Cell Lymphoma  (MCL)
t(11;18) API2/MLT for MALT Lymphoma
t(12;21) ETV6-RUNX1 or TEL-AML1 / t(12;21) for ALL (Qualitative)
t(12;21) ETV6-RUNX1 or TEL-AML1 / t(12;21) for ALL (Quantitative)
t(14;18) IgH/BCL2 (MBR) for Follicular Lymphoma
t(14;18) IgH/BCL2 (MBR) or IgH/BCL2 / t(14;18) for Follicular lymphoma
t(14;18) IgH/BCL2 (mcr) for Follicular Lymphoma
t(14;18) IgH/BCL2 (mcr) or IgH/BCL2 / t(14;18) for Follicular lymphoma
t(15;17) PML-RARA for AML-M3 and M3v  (Quantitative)
t(15;17) PML-RARA for AML-M3 and M3v (Qualitative)
T(2:13) or PAX3-FKHR for Rhabdomyo sarcoma
t(2;13) PAX3/FOXO1A (FKHR) for Alveolar Rhabdomyosarcoma
t(2;13) PAX3/FOXO1A (FKHR) for Alveolar Rhabdomyosarcoma
t(4;11) MLL-AF4 for ALL
t(8;14) IgH/c-Myc for Burkitt Lymphoma / ALL- L3
t(8;14)IgH/c-Myc & t(8;22) IgL/c-Myc & t(2;8) IgK/c-Myc for Burkitt Lymphoma -FISH
t(8;21)(q22;q22.1);RUNX1-RUNX1T1 or AML1-ETO/t(8;21)
T-ALL Body fluid panel ( 3-5 CD markers)
T-cell LGL Leukemia panel at diagnosis ( 16-18 CD markers)
TCR-γ (Gamma) gene rearrangement  B ( Clonality Assay)
TCR-γ (Gamma) gene rearrangement A (Clonality Assay)
TCR-γ gene  rearrangement for NHL
TCR-δ (Delta) gene rearrangement (Clonality Assay)
Thin prep
Thiopurine Meyhyl Transferase (TPMT) Toxicity to Azathioprin, 6 Mercaptopurine, 6 thioguanine
Toxoplasma gondii
Treponema pallidum